Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03906539Phase 4Completed
Phase 4, randomised, double-blind trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Change in serum High Density Lipoprotein (HDL) at 8 weeks. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03906539.